|
|
 Previous Article | Table of Contents | Next Article 
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Amy H. Yin,
Sheri Miraglia,
Esmail D. Zanjani,
Graca Almeida-Porada,
Makio Ogawa,
Anne G. Leary,
Johanna Olweus,
John Kearney, and
David W. Buck
From AmCell Corp, Sunnyvale, CA; Veterans Administration Medical Center, University of Nevada, Reno, NV; Ralph H. Johnson Department of Veterans Affairs Medical Center and the Department of Medicine, Medical University of South Carolina, Charleston, SC; Becton Dickinson Immunocytometry Systems, San Jose, CA; and Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL.
AC133 is one of a new panel of murine hybridoma lines producing monoclonal IgG antibodies (mAbs) to a novel stem cell glycoprotein antigen with a molecular weight of 120 kD. AC133 antigen is selectively expressed on CD34bright hematopoietic stem and progenitor cells (progenitors) derived from human fetal liver and bone marrow, and blood. It is not detectable on other blood cells, cultured human umbilical vein endothelial cells (HUVECs), fibroblast cell lines, or the myeloid leukemia cell line KG1a by standard flow cytometric procedures. All of the noncommitted CD34+ cell population, as well as the majority of CD34+ cells committed to the granulocytic/monocytic pathway, are stained with AC133 antibody. In vitro clonogenicity assays have demonstrated that the CD34+AC133+ double-positive population from adult bone marrow contains the majority of the CFU-GM, a proportion of the CFU-Mix, and a minor population of BFU-E. The CD34dim and AC133- population has been shown to contain the remaining progenitor cells. AC133-selected cells engraft successfully in a fetal sheep transplantation model, and human cells harvested from chimeric fetal sheep bone marrow have been shown to successfully engraft secondary recipients, providing evidence for the long-term repopulating potential of AC133+ cells. A cDNA coding for AC133 antigen has been isolated, which codes for a polypeptide consisting of 865 amino acids (aa) with a predicted size of 97 kD. This antigen is modeled as a 5-transmembrane molecule, a structure that is novel among known cell surface structures. AC133 antibody provides an alternative to CD34 for the selection and characterization of cells necessary for both short- and long-term engraftment, in transplant situations, for studies of ex vivo expansion strategies, and for gene therapy.
Blood, Vol. 90 No. 12 (December 15), 1997:
pp. 5002-5012
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder
Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts
Stroke,
July 1, 2008;
39(7):
2158 - 2165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Dirks
Brain Tumor Stem Cells: Bringing Order to the Chaos of Brain Cancer
J. Clin. Oncol.,
June 10, 2008;
26(17):
2916 - 2924.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.E. Schwab, P. Hutchinson, and C.E. Gargett
Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells
Hum. Reprod.,
April 1, 2008;
23(4):
934 - 943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Hess, T. P. Craft, L. Wirthlin, S. Hohm, P. Zhou, W. C. Eades, M. H. Creer, M. S. Sands, and J. A. Nolta
Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity
Stem Cells,
March 1, 2008;
26(3):
611 - 620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. B. Huttner, P. Janich, M. Kohrmann, J. Jaszai, F. Siebzehnrubl, I. Blumcke, M. Suttorp, M. Gahr, D. Kuhnt, C. Nimsky, et al.
The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease
Stem Cells,
March 1, 2008;
26(3):
698 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Shantsila, T. Watson, H.-F. Tse, and G. Y.H. Lip
New insights on endothelial progenitor cell subpopulations and their angiogenic properties.
J. Am. Coll. Cardiol.,
February 12, 2008;
51(6):
669 - 671.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori
Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer
Ann. Surg. Oncol.,
February 1, 2008;
15(2):
638 - 648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zeppernick, R. Ahmadi, B. Campos, C. Dictus, B. M. Helmke, N. Becker, P. Lichter, A. Unterberg, B. Radlwimmer, and C. C. Herold-Mende
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Clin. Cancer Res.,
January 1, 2008;
14(1):
123 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. I. Chang, S. A. Loh, D. J. Ceradini, E. I. Chang, S.-e Lin, N. Bastidas, S. Aarabi, D. A. Chan, M. L. Freedman, A. J. Giaccia, et al.
Age Decreases Endothelial Progenitor Cell Recruitment Through Decreases in Hypoxia-Inducible Factor 1{alpha} Stabilization During Ischemia
Circulation,
December 11, 2007;
116(24):
2818 - 2829.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-J. Liao, C. C. Zhang, B. Zhou, D. B. Zimonjic, S. A. Mani, M. Kaba, A. Gifford, F. Reinhardt, N. C. Popescu, W. Guo, et al.
Enrichment of a Population of Mammary Gland Cells that Form Mammospheres and Have In vivo Repopulating Activity
Cancer Res.,
September 1, 2007;
67(17):
8131 - 8138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Yanagisawa and R. K Yu
The expression and functions of glycoconjugates in neural stem cells
Glycobiology,
July 1, 2007;
17(7):
57R - 74R.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Timmermans, F. Van Hauwermeiren, M. De Smedt, R. Raedt, F. Plasschaert, M. L. De Buyzere, T. C. Gillebert, J. Plum, and B. Vandekerckhove
Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1572 - 1579.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagano, T. Yamashita, H. Hamada, K. Ohneda, K.-i. Kimura, T. Nakagawa, M. Shibuya, H. Yoshikawa, and O. Ohneda
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood
Blood,
July 1, 2007;
110(1):
151 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Pfenninger, T. Roschupkina, F. Hertwig, D. Kottwitz, E. Englund, J. Bengzon, S. E. Jacobsen, and U. A. Nuber
CD133 Is Not Present on Neurogenic Astrocytes in the Adult Subventricular Zone, but on Embryonic Neural Stem Cells, Ependymal Cells, and Glioblastoma Cells
Cancer Res.,
June 15, 2007;
67(12):
5727 - 5736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Balasubramaniam, C. F. Mervis, A. M. Maxey, N. E. Markham, and S. H. Abman
Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia
Am J Physiol Lung Cell Mol Physiol,
May 1, 2007;
292(5):
L1073 - L1084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yamada, S.-i. Yokoyama, X.-D. Wang, N. Fukuda, and N. Takakura
Cardiac Stem Cells in Brown Adipose Tissue Express CD133 and Induce Bone Marrow Nonhematopoietic Cells to Differentiate into Cardiomyocytes
Stem Cells,
May 1, 2007;
25(5):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava, and J. S. Rhim
Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens
Cancer Res.,
April 1, 2007;
67(7):
3153 - 3161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Casamassimi, M. L. Balestrieri, C. Fiorito, C. Schiano, C. Maione, R. Rossiello, V. Grimaldi, V. Del Giudice, C. Balestrieri, B. Farzati, et al.
Comparison Between Total Endothelial Progenitor Cell Isolation Versus Enriched Cd133+ Culture
J. Biochem.,
April 1, 2007;
141(4):
503 - 511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fazel
Bone marrow cell therapy for heart disease: A few good men and women wanted
J. Thorac. Cardiovasc. Surg.,
March 1, 2007;
133(3):
599 - 600.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Tan, H. Shao, D. Eton, Z. Yang, L. Alonso-Diaz, H. Zhang, A. Schulick, A. S. Livingstone, and H. Yu
Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor
Cardiovasc Res,
March 1, 2007;
73(4):
823 - 832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Dubreuil, A.-M. Marzesco, D. Corbeil, W. B. Huttner, and M. Wilsch-Brauninger
Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1
J. Cell Biol.,
February 12, 2007;
176(4):
483 - 495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Perrella, P Brusini, R Spelat, P Hossain, A Hopkinson, and H S Dua
Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes
Br. J. Ophthalmol.,
January 1, 2007;
91(1):
94 - 99.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi
CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis
Am. J. Pathol.,
December 1, 2006;
169(6):
2223 - 2235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Y. Frank, A. T. Kho, T. Schatton, G. F. Murphy, M. J. Molloy, Q. Zhan, M. F. Ramoni, M. H. Frank, I. S. Kohane, and E. Gussoni
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin
J. Cell Biol.,
October 9, 2006;
175(1):
99 - 110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Mehra, M. Penning, J. Maas, L. V. Beerepoot, N. van Daal, C. H. van Gils, R. H. Giles, and E. E. Voest
Progenitor Marker CD133 mRNA Is Elevated in Peripheral Blood of Cancer Patients with Bone Metastases.
Clin. Cancer Res.,
August 15, 2006;
12(16):
4859 - 4866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Fan, W. Matsui, L. Khaki, D. Stearns, J. Chun, Y.-M. Li, and C. G. Eberhart
Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors.
Cancer Res.,
August 1, 2006;
66(15):
7445 - 7452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Boyle, S. P. Schulman, and J. M. Hare
Stem Cell Therapy for Cardiac Repair: Ready for the Next Step
Circulation,
July 25, 2006;
114(4):
339 - 352.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al.
Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells
Cardiovasc Res,
July 1, 2006;
71(1):
158 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Sheridan, D. Rice, P. S. Hiscott, D. Wong, and D. L. Kent
The Presence of AC133-Positive Cells Suggests a Possible Role of Endothelial Progenitor Cells in the Formation of Choroidal Neovascularization.
Invest. Ophthalmol. Vis. Sci.,
April 1, 2006;
47(4):
1642 - 1645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Goussetis, M. Theodosaki, G. Paterakis, C. Tsecoura, and S. Graphakos
In Vitro Identification of a Cord Blood CD133+CD34-Lin+ Cell Subset that Gives Rise to Myeloid Dendritic Precursors
Stem Cells,
April 1, 2006;
24(4):
1137 - 1140.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. I. Peinado, J. Ramirez, J. Roca, R. Rodriguez-Roisin, and J. A. Barbera
Identification of Vascular Progenitor Cells in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol.,
March 1, 2006;
34(3):
257 - 263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Giebel, T. Zhang, J. Beckmann, J. Spanholtz, P. Wernet, A. D. Ho, and M. Punzel
Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division
Blood,
March 1, 2006;
107(5):
2146 - 2152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells
Blood,
March 1, 2006;
107(5):
2162 - 2169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Muguruma, T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando
Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment
Blood,
March 1, 2006;
107(5):
1878 - 1887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Hill, M. A. Syed, A. E. Arai, T. M. Powell, J. D. Paul, G. Zalos, E. J. Read, H. M. Khuu, S. F. Leitman, M. Horne, et al.
Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery Disease
J. Am. Coll. Cardiol.,
November 1, 2005;
46(9):
1643 - 1648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Yanagisawa, C. Endo, K. Okawa, S. Shitara, H. Kugoh, M. Kakitani, M. Oshimura, and K. Tomizuka
Generation of Chromosome-Specific Monoclonal Antibodies Using In Vitro-Differentiated Transchromosomic Mouse Embryonic Stem Cells
Stem Cells,
October 1, 2005;
23(10):
1479 - 1488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Elsheikh, M. Uzunel, Z. He, J. Holgersson, G. Nowak, and S. Sumitran-Holgersson
Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity
Blood,
October 1, 2005;
106(7):
2347 - 2355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, N. Hersmus, V. V. Duppen, P. Caesens, C. Denef, and H. Vankelecom
The Adult Pituitary Contains a Cell Population Displaying Stem/Progenitor Cell and Early Embryonic Characteristics
Endocrinology,
September 1, 2005;
146(9):
3985 - 3998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Akimov, A. Ramezani, T. S. Hawley, and R. G. Hawley
Bypass of Senescence, Immortalization, and Transformation of Human Hematopoietic Progenitor Cells
Stem Cells,
September 1, 2005;
23(9):
1423 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. J. Woo, T. J. Grand, M. F. Berry, P. Atluri, M. A. Moise, V. M. Hsu, J. Cohen, O. Fisher, J. Burdick, M. Taylor, et al.
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy
J. Thorac. Cardiovasc. Surg.,
August 1, 2005;
130(2):
321 - 329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Bauer, R. J. Bauer, and O. C. Velazquez
Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds
Vascular and Endovascular Surgery,
July 1, 2005;
39(4):
293 - 306.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A.-M. Marzesco, P. Janich, M. Wilsch-Brauninger, V. Dubreuil, K. Langenfeld, D. Corbeil, and W. B. Huttner
Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells
J. Cell Sci.,
July 1, 2005;
118(13):
2849 - 2858.
[Abstract]
| |
